CKD-828 S-Amlodipine Non-Responder Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 187 participants.

Also called NCT01501253

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 187 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01501253
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01501253. Randomized; triple masking; primary purpose treatment. Start 2011-08 (registry gives no type); primary completion 2012-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CKD-828 S-Amlodipine Non-Responder Trial
Condition
Hypertension
Intervention (Drug)
CKD-828 2.5/40mg
Intervention (Drug)
CKD-828 2.5/80mg
Intervention (Drug)
S-Amlodipine 2.5mg
Lead sponsor
Chong Kun Dang Pharmaceutical (class: industry)

Record details

Record id
cardio:ct-nct01501253
Content hash
927daf08177ec9ceaee7af00e5d750a9e3909ff10cb0084db1efc13fa4289c93